Esam Baryun, MD
Cardiovascular Disease · Huntington, WVNPI 1962504829
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (49.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Medtronic at 26.5% of the total. Among cardiovascular disease clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 728 payments — averaging $76.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$15K
- Abbott$12K
- Boston Scientific$10K
- Biosense Webster, Inc.$10K
- Medical Device Business Services, Inc.$2K
- Atricure, Inc.$2K
- plus $5K from 29 others
Across 43 payments — averaging $1284.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$53K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
What the payments were for
- Consulting fees$3,0005%
- Speaking & faculty fees$5,50010%
- Travel & lodging$27,56150%
- Food & beverage$19,18735%
- Education$2100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 180 | $14,692 |
| Abbott | 127 | $11,783 |
| Boston Scientific | 100 | $10,082 |
| Biosense Webster, Inc. | 18 | $9,557 |
| Medical Device Business Services, Inc. | 6 | $2,480 |
| Atricure, Inc. | 11 | $1,704 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 93 | $1,688 |
| Pfizer | 39 | $496 |
| Novartis | 25 | $430 |
| Philips North America LLC | 6 | $308 |
| Johnson & Johnson | 25 | $300 |
| Impulse Dynamics (USA) Inc. | 2 | $262 |
| Cook Medical LLC | 14 | $252 |
| E.r. Squibb & Sons, L.L.C. | 21 | $196 |
| Chiesi USA, Inc. | 9 | $145 |
| Inspire Medical Systems, Inc. | 1 | $138 |
| Boehringer Ingelheim | 8 | $120 |
| Amgen | 9 | $113 |
| Davol Inc. | 2 | $101 |
| Paratek Pharmaceuticals, Inc. | 5 | $91 |
| AstraZeneca | 6 | $83 |
| Kestra Medical Technology Services, Inc. | 2 | $81 |
| Cvrx, Inc. | 2 | $47 |
| Lundbeck LLC | 3 | $47 |
| Shield Therapeutics Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $38 |
| Angiodynamics, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Cardiva Medical, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Merck | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Elutia, Inc. | 1 | $15 |
| Biotronik Inc. | 1 | $15 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto Smarttouch$9,046
- Carto 3 System$6,046
- Carto CFAE$6,046
- CartoSound$6,046
- ENSITE PRECISION$4,516
- EMBLEM MRI S-ICD$3,106
- ENSITE$2,804
- Carto 3$2,430
- GENERAL TACHY$1,250
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,123
- AGILIS$1,097
- AVEIR$930
- ARCTIC FRONT ADVANCE$828
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- CARDIOBLATE CRYOFLEX$743
- NA$598
- PulseSelect$468
- SYNERGY ABLATION SYSTEM$443
- OPTIMIZER$375
- COBALT DR MRI SURESCAN$362
How this compares
$55,458 in reported general payments places this provider in the 95th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 262 | $333,596 |
| MultaqDronedarone Hcl | 170 | $182,814 |
| XareltoRivaroxaban | 106 | $116,824 |
| Flecainide Acetate | 695 | $22,023 |
| Metoprolol Succinate | 657 | $10,502 |
| Dofetilide | 37 | $5,009 |
| Mexiletine Hcl | 41 | $3,655 |
| SotalolSotalol Hcl | 178 | $3,338 |
| Amiodarone Hcl | 114 | $2,038 |
| Propafenone Hcl | 47 | $1,786 |
| Digoxin | 50 | $945 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 58 | $743 |
| Carvedilol | 44 | $448 |
| Diltiazem Hcl | 12 | $372 |
| Lisinopril | 22 | $237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $496 | $333,596262 claims |
| Sanofi-aventis U.S. LLCMultaq | $20 | $182,814170 claims |
| Johnson & JohnsonXarelto | $300 | $116,824106 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Huntington
- Kofi OseiHuntington$87K
- Rameez SayyedHuntington$21K
- Jason MaderHuntington$13K
- Samian SulaimanHuntington$7K
- Mark StudenyHuntington$7K
- Ellen ThompsonHuntington$6K
- Amrit ThakurHuntington$5K
- Mehiar El-HamdaniHuntington$4K
- George LinsenmeyerHuntington$2K
- Sarah RinehartCharleston$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.